| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Cue Biopharma, Inc. (CUE) has 10 insiders with recent SEC Form 4 filings, including 6 buys and 12 sells. CUE is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.88M | $65.63M | - | |
| Other | 125.0K | $4.38M | - | |
| VP | 70.0K | $2.45M | - | |
| Other | 50.0K | $1.75M | - | |
| Dir | 24.4K | $854.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 5, 2020 | Suri Anish69 | President And CSO | Sale+OE | 800 | $20.01 | $16,008.00 | -2.3% | |
| Aug 4, 2020 | Suri Anish69 | President And CSO | Sale+OE | 6,200 | $20.02 | $124,114.00 | -8.2% | |
| Aug 4, 2020 | Sandercock Colin | SVP, General Counsel And Sec | Sale+OE | 6,626 | $20.00 | $132,530.05 | -16.2% | |
| Jun 24, 2020 | Fletcher Aaron G.L.55 | Director | Buy | 7,500 | $24.88 | $186,571.80 | +2.4% | |
| Dec 31, 2019 | Marlett Christopher A | Director | Sell | 24,700 | $16.28 | $402,209.00 | -1.6% | |
| Dec 26, 2019 | Marlett Christopher A | Director | Sell | 36,647 | $17.20 | $630,351.91 | -2.3% | |
| Dec 19, 2019 | Marlett Christopher A | Director | Sell | 24,732 | $15.94 | $394,114.36 | -1.5% | |
| Jun 21, 2019 | Passeri Daniel R | CEO And President | Buy | 1,377 | $7.26 | $9,997.02 | +2.7% | |
| Jun 10, 2019 | Sandercock Colin | SVP, General Counsel And Sec | Buy | 16,938 | $7.83 | $132,658.34 | +846.9% | |
| Jun 6, 2019 | Passeri Daniel R | CEO And President | Buy | 3,000 | $6.90 | $20,700.00 | +6.3% |